nodes	percent_of_prediction	percent_of_DWPC	metapath
Ardeparin—Local reaction—Epirubicin—urinary bladder cancer	0.00548	0.00548	CcSEcCtD
Ardeparin—Vesiculobullous rash—Epirubicin—urinary bladder cancer	0.00541	0.00541	CcSEcCtD
Ardeparin—Confusional state—Mitomycin—urinary bladder cancer	0.00539	0.00539	CcSEcCtD
Ardeparin—Oedema—Mitomycin—urinary bladder cancer	0.00534	0.00534	CcSEcCtD
Ardeparin—Diarrhoea—Valrubicin—urinary bladder cancer	0.00531	0.00531	CcSEcCtD
Ardeparin—Shock—Mitomycin—urinary bladder cancer	0.00526	0.00526	CcSEcCtD
Ardeparin—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.00523	0.00523	CcSEcCtD
Ardeparin—Skin exfoliation—Etoposide—urinary bladder cancer	0.00517	0.00517	CcSEcCtD
Ardeparin—Local reaction—Doxorubicin—urinary bladder cancer	0.00507	0.00507	CcSEcCtD
Ardeparin—Vesiculobullous rash—Doxorubicin—urinary bladder cancer	0.00501	0.00501	CcSEcCtD
Ardeparin—Aspartate aminotransferase increased—Thiotepa—urinary bladder cancer	0.00492	0.00492	CcSEcCtD
Ardeparin—Thrombocytosis—Epirubicin—urinary bladder cancer	0.00488	0.00488	CcSEcCtD
Ardeparin—Headache—Valrubicin—urinary bladder cancer	0.00486	0.00486	CcSEcCtD
Ardeparin—Alanine aminotransferase increased—Thiotepa—urinary bladder cancer	0.00482	0.00482	CcSEcCtD
Ardeparin—Dermatitis bullous—Gemcitabine—urinary bladder cancer	0.00481	0.00481	CcSEcCtD
Ardeparin—Dyspnoea—Mitomycin—urinary bladder cancer	0.00476	0.00476	CcSEcCtD
Ardeparin—Liver disorder—Methotrexate—urinary bladder cancer	0.00475	0.00475	CcSEcCtD
Ardeparin—Anaphylactoid reaction—Gemcitabine—urinary bladder cancer	0.00475	0.00475	CcSEcCtD
Ardeparin—Dermatitis bullous—Fluorouracil—urinary bladder cancer	0.00473	0.00473	CcSEcCtD
Ardeparin—Cardiac failure—Gemcitabine—urinary bladder cancer	0.00471	0.00471	CcSEcCtD
Ardeparin—Paralysis—Methotrexate—urinary bladder cancer	0.00466	0.00466	CcSEcCtD
Ardeparin—Cardiac failure—Fluorouracil—urinary bladder cancer	0.00463	0.00463	CcSEcCtD
Ardeparin—Nausea—Valrubicin—urinary bladder cancer	0.00461	0.00461	CcSEcCtD
Ardeparin—Pain—Mitomycin—urinary bladder cancer	0.00457	0.00457	CcSEcCtD
Ardeparin—Thrombocytosis—Doxorubicin—urinary bladder cancer	0.00451	0.00451	CcSEcCtD
Ardeparin—Anaphylactoid reaction—Cisplatin—urinary bladder cancer	0.00443	0.00443	CcSEcCtD
Ardeparin—Feeling abnormal—Mitomycin—urinary bladder cancer	0.0044	0.0044	CcSEcCtD
Ardeparin—Paralysis—Epirubicin—urinary bladder cancer	0.00436	0.00436	CcSEcCtD
Ardeparin—Thrombosis—Epirubicin—urinary bladder cancer	0.00428	0.00428	CcSEcCtD
Ardeparin—Pneumonia—Thiotepa—urinary bladder cancer	0.00424	0.00424	CcSEcCtD
Ardeparin—Body temperature increased—Mitomycin—urinary bladder cancer	0.00422	0.00422	CcSEcCtD
Ardeparin—Hyperlipidaemia—Epirubicin—urinary bladder cancer	0.00421	0.00421	CcSEcCtD
Ardeparin—Aspartate aminotransferase increased—Gemcitabine—urinary bladder cancer	0.00414	0.00414	CcSEcCtD
Ardeparin—Dermatitis atopic—Epirubicin—urinary bladder cancer	0.0041	0.0041	CcSEcCtD
Ardeparin—Anaphylactoid reaction—Etoposide—urinary bladder cancer	0.00406	0.00406	CcSEcCtD
Ardeparin—Alanine aminotransferase increased—Gemcitabine—urinary bladder cancer	0.00406	0.00406	CcSEcCtD
Ardeparin—Paralysis—Doxorubicin—urinary bladder cancer	0.00404	0.00404	CcSEcCtD
Ardeparin—Cardiac failure—Etoposide—urinary bladder cancer	0.00402	0.00402	CcSEcCtD
Ardeparin—Haematuria—Thiotepa—urinary bladder cancer	0.00402	0.00402	CcSEcCtD
Ardeparin—Thrombosis—Doxorubicin—urinary bladder cancer	0.00396	0.00396	CcSEcCtD
Ardeparin—Hyperlipidaemia—Doxorubicin—urinary bladder cancer	0.00389	0.00389	CcSEcCtD
Ardeparin—Eosinophilia—Fluorouracil—urinary bladder cancer	0.00387	0.00387	CcSEcCtD
Ardeparin—Aspartate aminotransferase increased—Cisplatin—urinary bladder cancer	0.00386	0.00386	CcSEcCtD
Ardeparin—Rash pustular—Epirubicin—urinary bladder cancer	0.0038	0.0038	CcSEcCtD
Ardeparin—Haemoglobin—Thiotepa—urinary bladder cancer	0.0038	0.0038	CcSEcCtD
Ardeparin—Dermatitis atopic—Doxorubicin—urinary bladder cancer	0.00379	0.00379	CcSEcCtD
Ardeparin—Haemorrhage—Thiotepa—urinary bladder cancer	0.00378	0.00378	CcSEcCtD
Ardeparin—Injection site pain—Epirubicin—urinary bladder cancer	0.00371	0.00371	CcSEcCtD
Ardeparin—Diarrhoea—Mitomycin—urinary bladder cancer	0.00366	0.00366	CcSEcCtD
Ardeparin—Pneumonia—Gemcitabine—urinary bladder cancer	0.00356	0.00356	CcSEcCtD
Ardeparin—Rash pustular—Doxorubicin—urinary bladder cancer	0.00352	0.00352	CcSEcCtD
Ardeparin—Pneumonia—Fluorouracil—urinary bladder cancer	0.0035	0.0035	CcSEcCtD
Ardeparin—Myocardial infarction—Gemcitabine—urinary bladder cancer	0.00347	0.00347	CcSEcCtD
Ardeparin—Alanine aminotransferase increased—Etoposide—urinary bladder cancer	0.00346	0.00346	CcSEcCtD
Ardeparin—Injection site pain—Doxorubicin—urinary bladder cancer	0.00344	0.00344	CcSEcCtD
Ardeparin—Myocardial infarction—Fluorouracil—urinary bladder cancer	0.00342	0.00342	CcSEcCtD
Ardeparin—Haematuria—Gemcitabine—urinary bladder cancer	0.00338	0.00338	CcSEcCtD
Ardeparin—Headache—Mitomycin—urinary bladder cancer	0.00335	0.00335	CcSEcCtD
Ardeparin—Alopecia—Thiotepa—urinary bladder cancer	0.00334	0.00334	CcSEcCtD
Ardeparin—Inflammation—Methotrexate—urinary bladder cancer	0.00334	0.00334	CcSEcCtD
Ardeparin—Vasculitis—Methotrexate—urinary bladder cancer	0.00332	0.00332	CcSEcCtD
Ardeparin—Erythema—Thiotepa—urinary bladder cancer	0.00329	0.00329	CcSEcCtD
Ardeparin—Myocardial infarction—Cisplatin—urinary bladder cancer	0.00324	0.00324	CcSEcCtD
Ardeparin—Haemoglobin—Gemcitabine—urinary bladder cancer	0.0032	0.0032	CcSEcCtD
Ardeparin—Haemorrhage—Gemcitabine—urinary bladder cancer	0.00318	0.00318	CcSEcCtD
Ardeparin—Nausea—Mitomycin—urinary bladder cancer	0.00317	0.00317	CcSEcCtD
Ardeparin—Haemoglobin—Fluorouracil—urinary bladder cancer	0.00314	0.00314	CcSEcCtD
Ardeparin—Oedema peripheral—Gemcitabine—urinary bladder cancer	0.00313	0.00313	CcSEcCtD
Ardeparin—Haemorrhage—Fluorouracil—urinary bladder cancer	0.00313	0.00313	CcSEcCtD
Ardeparin—Inflammation—Epirubicin—urinary bladder cancer	0.00313	0.00313	CcSEcCtD
Ardeparin—Skin exfoliation—Methotrexate—urinary bladder cancer	0.00309	0.00309	CcSEcCtD
Ardeparin—Pneumonia—Etoposide—urinary bladder cancer	0.00304	0.00304	CcSEcCtD
Ardeparin—Anaemia—Thiotepa—urinary bladder cancer	0.00304	0.00304	CcSEcCtD
Ardeparin—Hepatocellular injury—Epirubicin—urinary bladder cancer	0.00303	0.00303	CcSEcCtD
Ardeparin—Hyperkalaemia—Epirubicin—urinary bladder cancer	0.00298	0.00298	CcSEcCtD
Ardeparin—Myocardial infarction—Etoposide—urinary bladder cancer	0.00297	0.00297	CcSEcCtD
Ardeparin—Ecchymosis—Methotrexate—urinary bladder cancer	0.00293	0.00293	CcSEcCtD
Ardeparin—Skin exfoliation—Epirubicin—urinary bladder cancer	0.0029	0.0029	CcSEcCtD
Ardeparin—Inflammation—Doxorubicin—urinary bladder cancer	0.00289	0.00289	CcSEcCtD
Ardeparin—Pulmonary oedema—Methotrexate—urinary bladder cancer	0.00288	0.00288	CcSEcCtD
Ardeparin—Alopecia—Gemcitabine—urinary bladder cancer	0.00281	0.00281	CcSEcCtD
Ardeparin—Hepatocellular injury—Doxorubicin—urinary bladder cancer	0.00281	0.00281	CcSEcCtD
Ardeparin—Erythema—Gemcitabine—urinary bladder cancer	0.00277	0.00277	CcSEcCtD
Ardeparin—Alopecia—Fluorouracil—urinary bladder cancer	0.00276	0.00276	CcSEcCtD
Ardeparin—Hyperkalaemia—Doxorubicin—urinary bladder cancer	0.00276	0.00276	CcSEcCtD
Ardeparin—Ecchymosis—Epirubicin—urinary bladder cancer	0.00274	0.00274	CcSEcCtD
Ardeparin—Erythema—Fluorouracil—urinary bladder cancer	0.00272	0.00272	CcSEcCtD
Ardeparin—Confusional state—Thiotepa—urinary bladder cancer	0.00271	0.00271	CcSEcCtD
Ardeparin—Diabetes mellitus—Methotrexate—urinary bladder cancer	0.0027	0.0027	CcSEcCtD
Ardeparin—Pulmonary oedema—Epirubicin—urinary bladder cancer	0.0027	0.0027	CcSEcCtD
Ardeparin—Skin exfoliation—Doxorubicin—urinary bladder cancer	0.00268	0.00268	CcSEcCtD
Ardeparin—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00263	0.00263	CcSEcCtD
Ardeparin—Alopecia—Cisplatin—urinary bladder cancer	0.00262	0.00262	CcSEcCtD
Ardeparin—Erythema—Cisplatin—urinary bladder cancer	0.00258	0.00258	CcSEcCtD
Ardeparin—Anaemia—Gemcitabine—urinary bladder cancer	0.00256	0.00256	CcSEcCtD
Ardeparin—Ecchymosis—Doxorubicin—urinary bladder cancer	0.00254	0.00254	CcSEcCtD
Ardeparin—Diabetes mellitus—Epirubicin—urinary bladder cancer	0.00253	0.00253	CcSEcCtD
Ardeparin—Anaemia—Fluorouracil—urinary bladder cancer	0.00252	0.00252	CcSEcCtD
Ardeparin—Malaise—Gemcitabine—urinary bladder cancer	0.0025	0.0025	CcSEcCtD
Ardeparin—Pulmonary oedema—Doxorubicin—urinary bladder cancer	0.0025	0.0025	CcSEcCtD
Ardeparin—Vascular purpura—Epirubicin—urinary bladder cancer	0.00246	0.00246	CcSEcCtD
Ardeparin—Anaphylactoid reaction—Methotrexate—urinary bladder cancer	0.00243	0.00243	CcSEcCtD
Ardeparin—Alopecia—Etoposide—urinary bladder cancer	0.0024	0.0024	CcSEcCtD
Ardeparin—Anaemia—Cisplatin—urinary bladder cancer	0.00239	0.00239	CcSEcCtD
Ardeparin—Diabetes mellitus—Doxorubicin—urinary bladder cancer	0.00234	0.00234	CcSEcCtD
Ardeparin—Malaise—Cisplatin—urinary bladder cancer	0.00233	0.00233	CcSEcCtD
Ardeparin—Dermatitis bullous—Epirubicin—urinary bladder cancer	0.0023	0.0023	CcSEcCtD
Ardeparin—Pain—Thiotepa—urinary bladder cancer	0.0023	0.0023	CcSEcCtD
Ardeparin—Purpura—Epirubicin—urinary bladder cancer	0.00228	0.00228	CcSEcCtD
Ardeparin—Vascular purpura—Doxorubicin—urinary bladder cancer	0.00228	0.00228	CcSEcCtD
Ardeparin—Anaphylactoid reaction—Epirubicin—urinary bladder cancer	0.00227	0.00227	CcSEcCtD
Ardeparin—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.00226	0.00226	CcSEcCtD
Ardeparin—Oedema—Gemcitabine—urinary bladder cancer	0.00226	0.00226	CcSEcCtD
Ardeparin—Cardiac failure—Epirubicin—urinary bladder cancer	0.00226	0.00226	CcSEcCtD
Ardeparin—Confusional state—Fluorouracil—urinary bladder cancer	0.00224	0.00224	CcSEcCtD
Ardeparin—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00222	0.00222	CcSEcCtD
Ardeparin—Oedema—Fluorouracil—urinary bladder cancer	0.00222	0.00222	CcSEcCtD
Ardeparin—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00221	0.00221	CcSEcCtD
Ardeparin—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00221	0.00221	CcSEcCtD
Ardeparin—Anaemia—Etoposide—urinary bladder cancer	0.00219	0.00219	CcSEcCtD
Ardeparin—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00218	0.00218	CcSEcCtD
Ardeparin—Urticaria—Thiotepa—urinary bladder cancer	0.00213	0.00213	CcSEcCtD
Ardeparin—Malaise—Etoposide—urinary bladder cancer	0.00213	0.00213	CcSEcCtD
Ardeparin—Dermatitis bullous—Doxorubicin—urinary bladder cancer	0.00213	0.00213	CcSEcCtD
Ardeparin—Body temperature increased—Thiotepa—urinary bladder cancer	0.00212	0.00212	CcSEcCtD
Ardeparin—Purpura—Doxorubicin—urinary bladder cancer	0.00211	0.00211	CcSEcCtD
Ardeparin—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00211	0.00211	CcSEcCtD
Ardeparin—Oedema—Cisplatin—urinary bladder cancer	0.00211	0.00211	CcSEcCtD
Ardeparin—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.0021	0.0021	CcSEcCtD
Ardeparin—Cardiac failure—Doxorubicin—urinary bladder cancer	0.00209	0.00209	CcSEcCtD
Ardeparin—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00206	0.00206	CcSEcCtD
Ardeparin—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00202	0.00202	CcSEcCtD
Ardeparin—Eosinophilia—Methotrexate—urinary bladder cancer	0.00201	0.00201	CcSEcCtD
Ardeparin—Aspartate aminotransferase increased—Epirubicin—urinary bladder cancer	0.00198	0.00198	CcSEcCtD
Ardeparin—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00198	0.00198	CcSEcCtD
Ardeparin—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00198	0.00198	CcSEcCtD
Ardeparin—Confusional state—Etoposide—urinary bladder cancer	0.00195	0.00195	CcSEcCtD
Ardeparin—Alanine aminotransferase increased—Epirubicin—urinary bladder cancer	0.00194	0.00194	CcSEcCtD
Ardeparin—Pain—Gemcitabine—urinary bladder cancer	0.00193	0.00193	CcSEcCtD
Ardeparin—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00193	0.00193	CcSEcCtD
Ardeparin—Pruritus—Thiotepa—urinary bladder cancer	0.0019	0.0019	CcSEcCtD
Ardeparin—Pain—Fluorouracil—urinary bladder cancer	0.0019	0.0019	CcSEcCtD
Ardeparin—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00189	0.00189	CcSEcCtD
Ardeparin—Eosinophilia—Epirubicin—urinary bladder cancer	0.00188	0.00188	CcSEcCtD
Ardeparin—Dyspnoea—Cisplatin—urinary bladder cancer	0.00188	0.00188	CcSEcCtD
Ardeparin—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00186	0.00186	CcSEcCtD
Ardeparin—Diarrhoea—Thiotepa—urinary bladder cancer	0.00184	0.00184	CcSEcCtD
Ardeparin—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	0.00183	0.00183	CcSEcCtD
Ardeparin—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00183	0.00183	CcSEcCtD
Ardeparin—Pneumonia—Methotrexate—urinary bladder cancer	0.00182	0.00182	CcSEcCtD
Ardeparin—Pain—Cisplatin—urinary bladder cancer	0.0018	0.0018	CcSEcCtD
Ardeparin—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	0.0018	0.0018	CcSEcCtD
Ardeparin—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00179	0.00179	CcSEcCtD
Ardeparin—Urticaria—Fluorouracil—urinary bladder cancer	0.00177	0.00177	CcSEcCtD
Ardeparin—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00176	0.00176	CcSEcCtD
Ardeparin—Eosinophilia—Doxorubicin—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Ardeparin—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Ardeparin—Haematuria—Methotrexate—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Ardeparin—Dyspnoea—Etoposide—urinary bladder cancer	0.00172	0.00172	CcSEcCtD
Ardeparin—Pneumonia—Epirubicin—urinary bladder cancer	0.00171	0.00171	CcSEcCtD
Ardeparin—Headache—Thiotepa—urinary bladder cancer	0.00168	0.00168	CcSEcCtD
Ardeparin—Body temperature increased—Cisplatin—urinary bladder cancer	0.00167	0.00167	CcSEcCtD
Ardeparin—Pain—Etoposide—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Ardeparin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Ardeparin—Haemoglobin—Methotrexate—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Ardeparin—Haemorrhage—Methotrexate—urinary bladder cancer	0.00163	0.00163	CcSEcCtD
Ardeparin—Haematuria—Epirubicin—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Ardeparin—Pruritus—Gemcitabine—urinary bladder cancer	0.0016	0.0016	CcSEcCtD
Ardeparin—Nausea—Thiotepa—urinary bladder cancer	0.0016	0.0016	CcSEcCtD
Ardeparin—Feeling abnormal—Etoposide—urinary bladder cancer	0.00159	0.00159	CcSEcCtD
Ardeparin—Pneumonia—Doxorubicin—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Ardeparin—Pruritus—Fluorouracil—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Ardeparin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00155	0.00155	CcSEcCtD
Ardeparin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00155	0.00155	CcSEcCtD
Ardeparin—Urticaria—Etoposide—urinary bladder cancer	0.00153	0.00153	CcSEcCtD
Ardeparin—Haemoglobin—Epirubicin—urinary bladder cancer	0.00153	0.00153	CcSEcCtD
Ardeparin—Body temperature increased—Etoposide—urinary bladder cancer	0.00153	0.00153	CcSEcCtD
Ardeparin—Haemorrhage—Epirubicin—urinary bladder cancer	0.00152	0.00152	CcSEcCtD
Ardeparin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00152	0.00152	CcSEcCtD
Ardeparin—Oedema peripheral—Epirubicin—urinary bladder cancer	0.0015	0.0015	CcSEcCtD
Ardeparin—Haematuria—Doxorubicin—urinary bladder cancer	0.0015	0.0015	CcSEcCtD
Ardeparin—Diarrhoea—Cisplatin—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Ardeparin—Alopecia—Methotrexate—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Ardeparin—Hypersensitivity—Etoposide—urinary bladder cancer	0.00142	0.00142	CcSEcCtD
Ardeparin—Erythema—Methotrexate—urinary bladder cancer	0.00142	0.00142	CcSEcCtD
Ardeparin—Haemoglobin—Doxorubicin—urinary bladder cancer	0.00142	0.00142	CcSEcCtD
Ardeparin—Headache—Gemcitabine—urinary bladder cancer	0.00142	0.00142	CcSEcCtD
Ardeparin—Haemorrhage—Doxorubicin—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Ardeparin—Headache—Fluorouracil—urinary bladder cancer	0.00139	0.00139	CcSEcCtD
Ardeparin—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.00139	0.00139	CcSEcCtD
Ardeparin—Pruritus—Etoposide—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Ardeparin—Alopecia—Epirubicin—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Ardeparin—Nausea—Gemcitabine—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Ardeparin—Erythema—Epirubicin—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Ardeparin—Diarrhoea—Etoposide—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Ardeparin—Nausea—Fluorouracil—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Ardeparin—Anaemia—Methotrexate—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Ardeparin—Malaise—Methotrexate—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Ardeparin—Nausea—Cisplatin—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Ardeparin—Alopecia—Doxorubicin—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Ardeparin—Erythema—Doxorubicin—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Ardeparin—Anaemia—Epirubicin—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Ardeparin—Headache—Etoposide—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Ardeparin—Malaise—Epirubicin—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Ardeparin—Confusional state—Methotrexate—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Ardeparin—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Ardeparin—Nausea—Etoposide—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Ardeparin—Anaemia—Doxorubicin—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Ardeparin—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Ardeparin—Malaise—Doxorubicin—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Ardeparin—Confusional state—Epirubicin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Ardeparin—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Ardeparin—Oedema—Epirubicin—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Ardeparin—Shock—Epirubicin—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Ardeparin—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Ardeparin—Dyspnoea—Methotrexate—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Ardeparin—Confusional state—Doxorubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Ardeparin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.001	0.001	CcSEcCtD
Ardeparin—Oedema—Doxorubicin—urinary bladder cancer	0.001	0.001	CcSEcCtD
Ardeparin—Pain—Methotrexate—urinary bladder cancer	0.000989	0.000989	CcSEcCtD
Ardeparin—Shock—Doxorubicin—urinary bladder cancer	0.000985	0.000985	CcSEcCtD
Ardeparin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.00098	0.00098	CcSEcCtD
Ardeparin—Dyspnoea—Epirubicin—urinary bladder cancer	0.000965	0.000965	CcSEcCtD
Ardeparin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000953	0.000953	CcSEcCtD
Ardeparin—Pain—Epirubicin—urinary bladder cancer	0.000925	0.000925	CcSEcCtD
Ardeparin—Urticaria—Methotrexate—urinary bladder cancer	0.000918	0.000918	CcSEcCtD
Ardeparin—Body temperature increased—Methotrexate—urinary bladder cancer	0.000914	0.000914	CcSEcCtD
Ardeparin—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000893	0.000893	CcSEcCtD
Ardeparin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000892	0.000892	CcSEcCtD
Ardeparin—Urticaria—Epirubicin—urinary bladder cancer	0.00086	0.00086	CcSEcCtD
Ardeparin—Pain—Doxorubicin—urinary bladder cancer	0.000856	0.000856	CcSEcCtD
Ardeparin—Body temperature increased—Epirubicin—urinary bladder cancer	0.000855	0.000855	CcSEcCtD
Ardeparin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000852	0.000852	CcSEcCtD
Ardeparin—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000825	0.000825	CcSEcCtD
Ardeparin—Pruritus—Methotrexate—urinary bladder cancer	0.000818	0.000818	CcSEcCtD
Ardeparin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000797	0.000797	CcSEcCtD
Ardeparin—Urticaria—Doxorubicin—urinary bladder cancer	0.000795	0.000795	CcSEcCtD
Ardeparin—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000791	0.000791	CcSEcCtD
Ardeparin—Diarrhoea—Methotrexate—urinary bladder cancer	0.000791	0.000791	CcSEcCtD
Ardeparin—Pruritus—Epirubicin—urinary bladder cancer	0.000765	0.000765	CcSEcCtD
Ardeparin—Diarrhoea—Epirubicin—urinary bladder cancer	0.00074	0.00074	CcSEcCtD
Ardeparin—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000738	0.000738	CcSEcCtD
Ardeparin—Headache—Methotrexate—urinary bladder cancer	0.000724	0.000724	CcSEcCtD
Ardeparin—Pruritus—Doxorubicin—urinary bladder cancer	0.000708	0.000708	CcSEcCtD
Ardeparin—Nausea—Methotrexate—urinary bladder cancer	0.000687	0.000687	CcSEcCtD
Ardeparin—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000685	0.000685	CcSEcCtD
Ardeparin—Headache—Epirubicin—urinary bladder cancer	0.000678	0.000678	CcSEcCtD
Ardeparin—Nausea—Epirubicin—urinary bladder cancer	0.000643	0.000643	CcSEcCtD
Ardeparin—Headache—Doxorubicin—urinary bladder cancer	0.000627	0.000627	CcSEcCtD
Ardeparin—Nausea—Doxorubicin—urinary bladder cancer	0.000595	0.000595	CcSEcCtD
